A Systematic Approach to Patients with Jaundice

Area of Science:

• Hepatology
• Gastroenterology
• Internal Medicine

Background:

• Jaundice presents as yellowing of the skin and eyes, indicating potential issues with bilirubin metabolism, hepatocellular dysfunction, or biliary obstruction.
• Clinical signs of jaundice manifest when serum bilirubin levels exceed 2.5-3 mg/dL, necessitating a systematic diagnostic evaluation.
• Understanding the pathophysiology of cholestasis and hyperbilirubinemia is crucial for diagnosing the underlying cause of jaundice.

Approach:

• Evaluation commences with liver chemistry tests, including bilirubin (conjugated and unconjugated), alkaline phosphatase, alanine aminotransferase, aspartate aminotransferase, and total protein.
• Elevated alkaline phosphatase suggests hepatobiliary causes, requiring assessment of hepatic synthetic function for effective treatment planning.
• Combining serologic evaluation with hepatobiliary imaging aids in elucidating the underlying disease mechanism.

Key Points:

• Jaundice is a symptom, not a disease, reflecting underlying disorders in bilirubin processing, liver cell function, or bile flow.
• A stepwise diagnostic strategy, integrating laboratory results and imaging, is vital for accurate diagnosis and improved patient outcomes.
• Key laboratory markers include bilirubin levels, liver enzymes (ALT, AST), alkaline phosphatase, and assessment of synthetic function.

Conclusions:

• A systematic diagnostic approach to jaundice, starting with pathophysiology and progressing through laboratory and imaging studies, is essential.
• This structured evaluation framework helps identify the specific cause of jaundice, whether related to cholestasis, bilirubin metabolism, or hepatocellular dysfunction.
• Implementing a stepwise diagnostic plan can lead to more efficient, cost-effective, and timely patient care for jaundice.